“Antibiotic resistance has now become a costly and dangerous problem,” The Economist writes in an article examining the factors that have contributed to the global rise of antibiotic resistant bacteria, ahead of next week’s World Health Day dedicated to the issue.

What To Do About Antibiotic Resistance: AÂ Lancet Infectious Diseases editorial describes the growing public concerns over a global rise in antimicrobial resistance. “Bearing in mind that our objective is to contain antibiotic resistance rather than eradicate it, several policies could be adopted to help guarantee a future for antibiotics,” the…

Main Take-Aways From GHME: Reflections on last week’s Global Health Metrics & Evaluation (GHME) conference in Seattle, Washington appeared in several blogs and a Lancet column: Lancet: Offline: Where was Europe? (Horton, 3/26) Karen Grepin’s “Global Health Blog”: A trip to the inside of the Global Health Sausage Factory (3/22)…

Increasing rates of multidrug-resistant tuberculosis (MDR-TB) “are hampering world health programs aimed at tackling TB and threaten to wipe out progress made against the disease, scientists said on Friday,” Reuters reports (Kelland, 3/18).

Congress Needs To Follow Through On TB Funding Commitments “Prevention and control of tuberculosis (TB) on our globe is crumbling” and “[i]t needs fixing,” retired pediatrician Elinor Graham writes in a Seattle Times opinion piece. She describes the burden of TB in developing countries and the costs associated with treatments,…

IRIN Examines Medical Tourism’s Affect In Southeast Asia IRIN examines how “rapid growth in medical tourism” in southeast Asian countries is affecting health systems in the region. According to the WHO, “medical tourism is leading to some highly skilled specialists, as well as other trained medical staff, leaving public health…

NBC News’ “World Blog” reports on the emergence of drug-resistant malaria along the border between Thailand and Cambodia. “The Pailin area [in Cambodia] is now the epicenter of a fight to contain a growing resistance to Artemisinin, which is the world’s main anti-malarial drug,” the blog writes before noting the global health community’s efforts to contain the spread of drug-resistant malaria.

In follow-up coverage of the WHO’s announcement Wednesday of a plan to contain the spread of artemisinin-resistant malaria, news outlets examined the scope of the problem, reactions to the plan and speculations by some of how the anticipated $175 million annual cost would be funded.